www.rupeedesk.in
Stocks of pharmaceutical companies are seen reacting to their individual numbers next week with some drug makers expected to post strong growth for Jul-Sep and others likely to detail weaker earnings. Sun Pharmaceutical Industries Ltd and Divi's Laboratories are seen posting good results, while Ranbaxy Laboratories Ltd is expected to post "very bad results".
So, Sun Pharma's and Divi's Laboratories' stocks are seen positive and Ranbaxy might lose on announcing results. Ranbaxy is likely to detail Jul-Sep earnings on Oct 29. Glenmark Pharmaceuticals Ltd is also likely to post good on-quarter earnings, which could cause its stock to gain
We expect some companies, which are more prone to the new drug pricing policy, may show a depressed growth this quarter. However with the US market growing fast, the earnings as such are not expected to be subdued. Companies such as Dr Reddy's Laboratories Ltd, Sun Pharma and Divi's Laboratories are seen positive.
Stocks of pharmaceutical companies are seen reacting to their individual numbers next week with some drug makers expected to post strong growth for Jul-Sep and others likely to detail weaker earnings. Sun Pharmaceutical Industries Ltd and Divi's Laboratories are seen posting good results, while Ranbaxy Laboratories Ltd is expected to post "very bad results".
So, Sun Pharma's and Divi's Laboratories' stocks are seen positive and Ranbaxy might lose on announcing results. Ranbaxy is likely to detail Jul-Sep earnings on Oct 29. Glenmark Pharmaceuticals Ltd is also likely to post good on-quarter earnings, which could cause its stock to gain
We expect some companies, which are more prone to the new drug pricing policy, may show a depressed growth this quarter. However with the US market growing fast, the earnings as such are not expected to be subdued. Companies such as Dr Reddy's Laboratories Ltd, Sun Pharma and Divi's Laboratories are seen positive.
